Ralf Schindler

Title: Ralf Schindler: Innovator in Hemodialysis Technology

Introduction

Ralf Schindler is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medical technology, particularly in the area of hemodialysis. With a total of two patents to his name, Schindler's work focuses on improving treatment options for patients undergoing chronic hemodialysis.

Latest Patents

Schindler's latest patents include a permselective membrane designed for treating vascular calcifications in chronic hemodialysis patients. This innovative hemodialysis membrane is characterized by its unique composition, which includes at least one hydrophobic polymer and at least one hydrophilic polymer. The membrane has a molecular weight retention cutoff (MWRO) of between 15 and 20 kD and a molecular weight cutoff (MWCO) of between 170-320 kD. Alternatively, it can also have a MWRO of between 8.5 kD and 14.0 kD and a MWCO of between 55 kD and 130 kD. This invention aims to enhance the treatment of vascular calcification, a common complication in hemodialysis patients.

Career Highlights

Throughout his career, Ralf Schindler has worked with prominent organizations such as Gambro Lundia AB and Charité-Universitätsmedizin Berlin. His experience in these institutions has allowed him to develop and refine his innovative ideas in medical technology.

Collaborations

Schindler has collaborated with notable colleagues, including Markus Storr and Bernd Krause. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Ralf Schindler's contributions to the field of hemodialysis technology demonstrate his commitment to improving patient care. His innovative patents reflect a deep understanding of the challenges faced by chronic hemodialysis patients and offer promising solutions for their treatment.